SCHEMBL7047600

SCHEMBL7047600

CNC(C)(C)C(=O)N1CCC(n2nc(-c3ccc(Nc4nc5cc(C)ccc5o4)cc3)c3c(N)ncnc32)CC1.CNC(C)(C)C(=O)N1CCC(n2nc(-c3ccc(Nc4nc5ccccc5o4)cc3)c3c(N)ncnc32)CC1.Cc1cc(C)c2oc(Nc3ccc(-c4nn(C5(C)N=CC=N5)c5ncnc(N)c45)cc3)nc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 16/20 0.52
IGF1R P08069 16/20 0.52
ERBB4 Q15303 15/20 0.52
AURKB Q96GD4 3/20 0.52
BTK Q06187 3/20 0.52
PLK4 O00444 2/20 0.52
MAPK13 O15264 2/20 0.52
PDPK1 O15530 2/20 0.52
DAPK3 O43293 2/20 0.52
JAK2 O60674 2/20 0.52
ROCK2 O75116 2/20 0.52
PAK4 O96013 2/20 0.52
ABL1 P00519 2/20 0.52
NTRK1 P04629 2/20 0.52
INSR P06213 2/20 0.52
LCK P06239 2/20 0.52
FYN P06241 2/20 0.52
CDK1 P06493 2/20 0.52
CSF1R P07333 2/20 0.52
LYN P07948 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4826510 0.86 EGFR (0.57) EGFRIGF1RERBB4AURKBBTK
SCHEMBL4820543 0.85 EGFR (0.69) EGFRIGF1RERBB4BTKLCK
SCHEMBL4818658 0.84 EGFR (0.62) EGFRIGF1RERBB4AURKBBTK
SCHEMBL4824621 0.81 EGFR (0.61) EGFRIGF1RERBB4AURKBBTK
SCHEMBL4826144 0.81 EGFR (0.58) EGFRIGF1RERBB4AURKBBTK
SCHEMBL4826042 0.80 EGFR (0.57) EGFRIGF1RERBB4AURKBBTK
SCHEMBL6430643 0.79 EGFR (0.70) EGFRIGF1RERBB4AURKBBTK
SCHEMBL4820389 0.79 KDR (0.61) EGFRIGF1RERBB4AURKBBTK
SCHEMBL6431893 0.78 EGFR (0.67) EGFRIGF1RERBB4AURKBBTK
SCHEMBL3891960 0.78 EGFR (0.72) EGFRIGF1RERBB4AURKBBTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004100868-A2 METHOD OF TREATING TRANSPLANT REJECTION ABBOTT LABORATORIES (US) 2004-11-25 WO disclosed